• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海拔2438米(8000英尺)处慢性阻塞性肺疾病患者严重低氧血症的发生情况。

Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude.

作者信息

Christensen C C, Ryg M, Refvem O K, Skjønsberg O H

机构信息

Dept of Pulmonary Medicine, Ulleval Hospital, Oslo, Norway.

出版信息

Eur Respir J. 2000 Apr;15(4):635-9. doi: 10.1183/09031936.00.15463500.

DOI:10.1183/09031936.00.15463500
PMID:10780752
Abstract

The arterial oxygen tensions (Pa,02) in chronic obstructive pulmonary disease (COPD) patients travelling by air, should, according to two different guidelines, not be lower than 7.3 kPa (55 mmHg) and 6.7 kPa (50 mmHg), respectively, at a cabin pressure altitude of 2,438 m (8,000 ft). These minimum in-flight Pa,O2 values are claimed to correspond to a minimum Pa,O2 of 9.3 kPa (70 mmHg) at sea-level. The authors have tested whether this limit is a safe criterion for predicting severe in-flight hypoxaemia. The authors measured arterial blood gases at sea-level, at 2,438 m and at 3,048 m (10,000 ft) in an altitude chamber at rest and during light exercise in 15 COPD patients with forced expiratory volume in one second (FEV1) <50% of predicted, and with sea-level Pa,O2 >9.3 kPa. Resting Pa,O2 decreased below 7.3 kPa and 6.7 kPa in 53% and 33% of the patients, respectively, at 2,438 m, and in 86% and 66% of the patients at 3,048 m. During light exercise, Pa,O2 dropped below 6.7 kPa in 86% of the patients at 2,438 m, and in 100% of the patients at 3,048 m. There was no correlation between Pa,O2 at 2,438 m and pre-flight values of Pa,O2, FEV1 or transfer factor of the lung for carbon monoxide. In contrast to current medical guidelines, it has been found that resting arterial oxygen tension >9.3 kPa at sea-level does not exclude development of severe hypoxaemia in chronic obstructive pulmonary disease patients travelling by air. Light exercise, equivalent to slow walking along the aisle, may provoke a pronounced aggravation of the hypoxaemia.

摘要

根据两项不同的指南,慢性阻塞性肺疾病(COPD)患者乘坐飞机时,在客舱压力高度为2438米(8000英尺)时,动脉血氧分压(PaO₂)分别不应低于7.3千帕(55毫米汞柱)和6.7千帕(50毫米汞柱)。这些飞行中最低的PaO₂值据称相当于海平面时最低PaO₂为9.3千帕(70毫米汞柱)。作者测试了这一限值是否是预测飞行中严重低氧血症的安全标准。作者在海拔高度舱内,对15例一秒用力呼气量(FEV₁)<预计值50%且海平面PaO₂>9.3千帕的COPD患者,在海平面、2438米和3048米(10000英尺)处,静息状态及轻度运动时测量动脉血气。在2438米处,分别有53%和33%的患者静息PaO₂降至7.3千帕和6.7千帕以下;在3048米处,分别有86%和66%的患者静息PaO₂降至7.3千帕和6.7千帕以下。在轻度运动时,在2438米处,86%的患者PaO₂降至6.7千帕以下;在3048米处,100%的患者PaO₂降至6.7千帕以下。2438米处的PaO₂与飞行前的PaO₂、FEV₁或肺一氧化碳转运因子值之间无相关性。与当前医学指南相反,研究发现海平面静息动脉血氧分压>9.3千帕并不能排除乘坐飞机的COPD患者发生严重低氧血症。相当于在过道缓慢行走的轻度运动可能会使低氧血症明显加重。

相似文献

1
Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude.海拔2438米(8000英尺)处慢性阻塞性肺疾病患者严重低氧血症的发生情况。
Eur Respir J. 2000 Apr;15(4):635-9. doi: 10.1183/09031936.00.15463500.
2
Effect of hypobaric hypoxia on blood gases in patients with restrictive lung disease.低压缺氧对限制性肺疾病患者血气的影响。
Eur Respir J. 2002 Aug;20(2):300-5. doi: 10.1183/09031936.02.00222302.
3
Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.模拟商业飞行对间质性肺疾病和慢性阻塞性肺疾病患者氧合的影响。
Thorax. 2004 Nov;59(11):966-70. doi: 10.1136/thx.2004.022210.
4
Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight.慢性阻塞性肺疾病患者在商业飞行过程中的低氧血症
Eur Respir J. 2005 Apr;25(4):725-30. doi: 10.1183/09031936.05.00093104.
5
Lung function in adults with cystic fibrosis at altitude: impact on air travel.成年囊性纤维化患者在高原地区的肺功能:对航空旅行的影响。
Eur Respir J. 2005 Apr;25(4):718-24. doi: 10.1183/09031936.05.10087304.
6
Exercise-induced hypoxaemia in emphysematous type chronic obstructive pulmonary disease.肺气肿型慢性阻塞性肺疾病中的运动诱发低氧血症
Monaldi Arch Chest Dis. 1996 Apr;51(2):117-9.
7
Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise.慢性阻塞性肺疾病(COPD)合并低氧血症患者在运动峰值时进行补充氧气训练。
Eur Respir J. 1997 Jun;10(6):1278-84. doi: 10.1183/09031936.97.10061278.
8
Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia.轻度低氧血症的慢性阻塞性肺疾病患者睡眠相关的氧饱和度下降及日间肺血流动力学情况
Eur Respir J. 1997 Aug;10(8):1730-5. doi: 10.1183/09031936.97.10081730.
9
COPD and air travel: does hypoxia-altitude simulation testing predict in-flight respiratory symptoms?慢性阻塞性肺疾病(COPD)与航空旅行:低氧-高空模拟测试能否预测飞行中呼吸系统症状?
Eur Respir J. 2013 Nov;42(5):1216-23. doi: 10.1183/09031936.00157112. Epub 2012 Dec 20.
10
Oxygen saturation during daily activities in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者日常活动期间的血氧饱和度
Eur Respir J. 1996 Dec;9(12):2584-9. doi: 10.1183/09031936.96.09122584.

引用本文的文献

1
Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude.指导慢性阻塞性肺疾病患者前往高海拔地区旅行。
High Alt Med Biol. 2023 Sep;24(3):158-166. doi: 10.1089/ham.2023.0053. Epub 2023 Aug 30.
2
Hypoxia-altitude simulation test to predict altitude-related adverse health effects in COPD patients.低氧-海拔模拟试验预测慢性阻塞性肺疾病患者与海拔相关的不良健康影响。
ERJ Open Res. 2023 Mar 13;9(2). doi: 10.1183/23120541.00488-2022. eCollection 2023 Mar.
3
BTS Clinical Statement on air travel for passengers with respiratory disease.
英国胸科学会关于呼吸系统疾病乘客航空旅行的临床声明。
Thorax. 2022 Apr;77(4):329-350. doi: 10.1136/thoraxjnl-2021-218110. Epub 2022 Feb 28.
4
Effects of Altitude on Chronic Obstructive Pulmonary Disease Patients: Risks and Care.海拔对慢性阻塞性肺疾病患者的影响:风险与护理
Life (Basel). 2021 Aug 7;11(8):798. doi: 10.3390/life11080798.
5
Exercise Capacity, Ventilatory Response, and Gas Exchange in COPD Patients With Mild to Severe Obstruction Residing at High Altitude.居住在高海拔地区的轻至重度阻塞性慢性阻塞性肺疾病(COPD)患者的运动能力、通气反应和气体交换
Front Physiol. 2021 Jun 18;12:668144. doi: 10.3389/fphys.2021.668144. eCollection 2021.
6
Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.夜间氧疗对慢性阻塞性肺疾病患者在海拔 2048 米旅行时夜间低氧血症和睡眠呼吸暂停的影响:一项随机临床试验。
JAMA Netw Open. 2020 Jun 1;3(6):e207940. doi: 10.1001/jamanetworkopen.2020.7940.
7
The effect of atmospheric pressure on oxygen saturation and dyspnea: the Tromsø study.大气压力对血氧饱和度和呼吸困难的影响:特罗姆瑟研究。
Int J Biometeorol. 2020 Jul;64(7):1103-1110. doi: 10.1007/s00484-020-01883-3. Epub 2020 Mar 3.
8
Are pulmonologists well aware of planning safe air travel for patients with COPD? The SAFCOP study.肺病学家是否非常了解为 COPD 患者规划安全的航空旅行?SAFCOP 研究。
Int J Chron Obstruct Pulmon Dis. 2019 Aug 22;14:1895-1900. doi: 10.2147/COPD.S210854. eCollection 2019.
9
Should I stay or should I go? COPD and air travel.我该留下还是离开?COPD 和航空旅行。
Eur Respir Rev. 2018 Jun 13;27(148). doi: 10.1183/16000617.0030-2018. Print 2018 Jun 30.
10
Pre-flight evaluation of adult patients with cystic fibrosis: a cross-sectional study.成年囊性纤维化患者的飞行前评估:一项横断面研究。
BMC Res Notes. 2017 Feb 6;10(1):84. doi: 10.1186/s13104-017-2386-2.